Skip to main content

Latest SEC Filings — Page 140

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Activant-Led Group Discloses Board and CEO Change Discussions, Potential 26.8% Stake
ProForm SCHEDULE 13D/ABETR · Form SCHEDULE 13D/A · 2026-08-15
Cosan Announces CFO/CLO Departures, NYSE Delisting, and Radar II Restructuring
ProForm 6-KCSAN · Form 6-K · 2026-08-15
Tenon Medical Amends S-3, Adds $4.4M ATM and Discloses Going Concern, Material Weakness, Delisting Risks
ProForm S-3/ATNON · Form S-3/A · 2026-08-15
Dogness Issues 3.05M Shares on Warrant Exercise, Cuts Acquisition Stake to 6.735%
Form 6-KDOGZ · Form 6-K · 2026-08-15
Cosan Reports 2Q26 Net Loss of R$320M, Cuts Net Debt 20% and Introduces DSCR Guidance
ProForm 6-KCSAN · Form 6-K · 2026-08-15
Ming Shing FY2026: Revenue Halves, Going Concern Warning, $620M in Acquisitions
ProForm 20-FPMA · Form 20-F · 2026-08-15
GMS Ventures Invests $2.5M in Outlook Therapeutics' $55M Offering
Form SCHEDULE 13D/AOTLK · Form SCHEDULE 13D/A · 2026-08-14
Director and 10% Owner Ghiath Sukhtian Invests $2.5M in Outlook Therapeutics Offering
ProForm 4OTLK · Form 4 · 2026-08-14
GreenPower Q1 FY2027: Revenue Collapses 72%, Cash Drops to $17K, Going Concern Doubt
ProForm 6-KGP · Form 6-K · 2026-08-14
Extreme Networks Swings to FY26 Profit; New $500M Credit Facility and Board Departure Disclosed
Form 10-KEXTR · Form 10-K · 2026-08-14
NexGel Q2 10-Q: Going Concern, Potential Note Defaults, and Material Weaknesses
ProForm 10-QNXGL · Form 10-Q · 2026-08-14
Grupo Aval Q2 2026 Net Income Jumps 71.6% QoQ to Ps 577.5B; ROAE Hits 12.7%
Form 6-KAVAL · Form 6-K · 2026-08-14
Activist Legion Partners Exits NN Inc, Sells 1.2M Shares Below 5% Stake
Form SCHEDULE 13D/ANNBR · Form SCHEDULE 13D/A · 2026-08-14
3i, LP Sells 11.7M Shares and Converts Preferred Stock, Raising Stake to 9.9%
ProForm SCHEDULE 13D/AVBIO · Form SCHEDULE 13D/A · 2026-08-14
Officer Kishore Seendripu Files to Sell $20.4M in MaxLinear Stock
Form 144MXL · Form 144 · 2026-08-14
Five9 Director Michael Burkland Files to Sell $6.15M in Stock
Form 144FIVN · Form 144 · 2026-08-14
Director Sam Levinson's Group Increases Stake to 40.9% with Recent Purchases
ProForm SCHEDULE 13D/ACLPR · Form SCHEDULE 13D/A · 2026-08-14
Atlas Venture intends to sell $8.37M in Dyne stock, continuing recent distribution
Form 144DYN · Form 144 · 2026-08-14
Director Sam Levinson Buys $488,796 of Clipper Realty Stock
Form 4CLPR · Form 4 · 2026-08-14
NexGel Seeks Shareholder Approval for Reverse Split and Up to 150M Authorized Shares
ProForm PRE 14ANXGL · Form PRE 14A · 2026-08-14
Onar Q2 Revenue Jumps 123% but Cash Drops to $40K; Going Concern Doubt Persists
ProForm 10-QONAR · Form 10-Q · 2026-08-14
Firsthand Technology Value Fund Reports Negative Net Assets and Reiterates Going Concern Warning
ProForm 10-QSVVC · Form 10-Q · 2026-08-14
Prairie Operating Co. Reports Q2 Revenue Surge but Faces Nasdaq Delisting and Liquidity Crunch
ProForm 10-QPROP · Form 10-Q · 2026-08-14
Valion Bio Q2 Loss Widens to $7.1M; Cash Drops to $2.1M, Going Concern Doubt Reiterated
ProForm 10-QVBIO · Form 10-Q · 2026-08-14
House of Doge 10-Q Flags Going Concern Doubt, Material Weakness, and $5.5M CleanCore Investment
ProForm 10-QHODO · Form 10-Q · 2026-08-14
Major Shareholder Sells 18.6M Shares for $111.7M, Stake Drops to 14.89%
ProForm SCHEDULE 13D/AMAAS · Form SCHEDULE 13D/A · 2026-08-14
Healthy Extracts Q2 Revenue Jumps 113% but Going Concern Doubt and $5.4M Insider Loan Weigh
ProForm 10-QHYEX · Form 10-Q · 2026-08-14
Comscore Q2 Loss Widens to $14.8M; Realignment Costs $7-9M
ProForm 10-QSCOR · Form 10-Q · 2026-08-14
Patriot National Bancorp Q2 2026: Material Weakness Persists, Credit Card Receivable Write-Down
ProForm 10-QPNBK · Form 10-Q · 2026-08-14
CEO Su-Leng Tan Lee Receives 338,709 Fully Vested Shares, Boosting Stake to 11.5%
Form SCHEDULE 13DBGLC · Form SCHEDULE 13D · 2026-08-14